KINIKSA PHARMACEUTICALS LTD

NASDAQ: KNSA (Kiniksa Pharmaceuticals Interna)

Last update: 4 days ago, 12:03PM

46.72

-0.31 (-0.66%)

  • 1D -0.66%
  • 5D -2.93%
  • 1M 2.05%
  • 6M 26.17%
  • YTD 11.22%
  • 1Y 125.81%
  • 5Y 197.58%
Previous Close 47.03
Open 46.69
Volume 335,203
Avg. Volume (3M) 643,705
Market Cap 3,575,732,736
Price / Earnings (TTM) 62.29
Price / Earnings (Forward) 59.52
Price / Sales 5.69
Price / Book 6.58
52 Weeks Range
18.26 (-60%) — 50.03 (7%)
Earnings Date 28 Apr 2026
Profit Margin -3.52%
Operating Margin (TTM) 9.63%
Diluted EPS (TTM) -0.240
Quarterly Revenue Growth (YOY) 72.50%
Total Debt/Equity (MRQ) 2.17%
Current Ratio (MRQ) 3.66
Operating Cash Flow (TTM) 44.03 M
Levered Free Cash Flow (TTM) 25.15 M
Return on Assets (TTM) -1.77%
Return on Equity (TTM) -3.81%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Bullish
Drug Manufacturers - Specialty & Generic (Global) Mixed Bullish
Stock Kiniksa Pharmaceuticals Interna Bullish Bullish

AIStockmoo Score

0.3
Analyst Consensus 4.0
Insider Activity -3.5
Price Volatility -0.5
Technical Moving Averages -2.5
Technical Oscillators 4.0
Average 0.30

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
KNSA 4 B - 62.29 6.58
BCRX 2 B - 7.90 56.59
AMLX 2 B - - 5.41
HROW 1 B - - 25.05
ALVO 1 B - 36.20 -
ETON 719 M - - 27.50

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Growth
% Held by Insiders 3.80%
% Held by Institutions 97.31%
52 Weeks Range
18.26 (-60%) — 50.03 (7%)
Price Target Range
53.00 (13%) — 62.00 (32%)
High 62.00 (Canaccord Genuity, 32.71%) Buy
Median 53.00 (13.44%)
Low 53.00 (Wedbush, 13.44%) Buy
53.00 (Wells Fargo, 13.44%) Buy
Average 56.00 (19.86%)
Total 3 Buy
Avg. Price @ Call 44.23
Firm Date Target Price Call Price @ Call
Wedbush 25 Feb 2026 53.00 (13.44%) Buy 42.76
13 Jan 2026 50.00 (7.02%) Buy 38.60
Wells Fargo 25 Feb 2026 53.00 (13.44%) Buy 42.76
Canaccord Genuity 19 Feb 2026 62.00 (32.71%) Buy 47.17
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
MEGNA MICHAEL R - 48.54 -4,871 -235,791
MOAT ROSS - 48.87 -4,847 -237,274
PAOLINI JOHN F. - 48.54 -4,029 -194,894
PATEL SANJ K - 48.87 -22,422 -1,093,419
QUART BARRY D - 49.55 -6,901 -341,945
RAGOSA MARK - 48.54 -3,813 -184,575
TESSARI EBEN - 48.54 -2,602 -125,920
Aggregate Net Quantity -49,485
Aggregate Net Value ($) -2,413,817
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 48.74
Name Holder Date Type Quantity Price Value ($)
MEGNA MICHAEL R Officer 07 Apr 2026 Disposed (-) 1,666 48.94 81,534
MEGNA MICHAEL R Officer 07 Apr 2026 Option execute 3,932 - -
MOAT ROSS Officer 07 Apr 2026 Disposed (-) 774 48.94 37,880
MOAT ROSS Officer 07 Apr 2026 Option execute 2,477 - -
PAOLINI JOHN F. Officer 07 Apr 2026 Disposed (-) 1,208 48.94 59,120
PAOLINI JOHN F. Officer 07 Apr 2026 Option execute 2,497 - -
PATEL SANJ K Officer 07 Apr 2026 Disposed (-) 4,831 48.94 236,429
PATEL SANJ K Officer 07 Apr 2026 Option execute 9,991 - -
RAGOSA MARK Officer 07 Apr 2026 Disposed (-) 1,303 48.94 63,769
RAGOSA MARK Officer 07 Apr 2026 Option execute 2,694 - -
TESSARI EBEN Officer 07 Apr 2026 Disposed (-) 846 48.94 41,403
TESSARI EBEN Officer 07 Apr 2026 Option execute 2,726 - -
QUART BARRY D Director 06 Apr 2026 Automatic sell (-) 6,901 49.55 341,945
QUART BARRY D Director 06 Apr 2026 Option execute 6,901 - -
MOAT ROSS Officer 06 Apr 2026 Automatic sell (-) 2,367 49.55 117,285
PATEL SANJ K Officer 06 Apr 2026 Automatic sell (-) 7,278 49.55 360,625
PATEL SANJ K Officer 06 Apr 2026 Option execute 7,278 - -
MEGNA MICHAEL R Officer 01 Apr 2026 Disposed (-) 3,205 48.13 154,257
MEGNA MICHAEL R Officer 01 Apr 2026 Option execute 7,564 - -
MOAT ROSS Officer 01 Apr 2026 Disposed (-) 1,706 48.13 82,110
MOAT ROSS Officer 01 Apr 2026 Option execute 5,808 - -
PAOLINI JOHN F. Officer 01 Apr 2026 Disposed (-) 2,821 48.13 135,775
PAOLINI JOHN F. Officer 01 Apr 2026 Option execute 5,831 - -
PATEL SANJ K Officer 01 Apr 2026 Disposed (-) 10,313 48.13 496,365
PATEL SANJ K Officer 01 Apr 2026 Option execute 21,327 - -
RAGOSA MARK Officer 01 Apr 2026 Disposed (-) 2,510 48.13 120,806
RAGOSA MARK Officer 01 Apr 2026 Option execute 5,187 - -
TESSARI EBEN Officer 01 Apr 2026 Disposed (-) 1,756 48.13 84,516
TESSARI EBEN Officer 01 Apr 2026 Option execute 5,975 - -
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria